ATE282023T1 - Benzamid-derivate zur behandlung cytokin- vermittelter krankheiten - Google Patents
Benzamid-derivate zur behandlung cytokin- vermittelter krankheitenInfo
- Publication number
- ATE282023T1 ATE282023T1 AT99921018T AT99921018T ATE282023T1 AT E282023 T1 ATE282023 T1 AT E282023T1 AT 99921018 T AT99921018 T AT 99921018T AT 99921018 T AT99921018 T AT 99921018T AT E282023 T1 ATE282023 T1 AT E282023T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- cytokine
- mediated diseases
- benzamide derivatives
- 6alkoxy
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- -1 C1-6akylthio Chemical group 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810356.7A GB9810356D0 (en) | 1998-05-15 | 1998-05-15 | Amide derivatives |
| GBGB9905970.1A GB9905970D0 (en) | 1999-03-17 | 1999-03-17 | Amide derivatives |
| PCT/GB1999/001491 WO1999059960A1 (en) | 1998-05-15 | 1999-05-11 | Benzamide derivatives for the treatment of diseases mediated by cytokines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE282023T1 true ATE282023T1 (de) | 2004-11-15 |
Family
ID=26313677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99921018T ATE282023T1 (de) | 1998-05-15 | 1999-05-11 | Benzamid-derivate zur behandlung cytokin- vermittelter krankheiten |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6465455B1 (de) |
| EP (1) | EP1077930B1 (de) |
| JP (1) | JP2003505337A (de) |
| KR (1) | KR100628284B1 (de) |
| CN (1) | CN1188389C (de) |
| AT (1) | ATE282023T1 (de) |
| AU (1) | AU748397B2 (de) |
| BR (1) | BR9910467A (de) |
| CA (1) | CA2328699A1 (de) |
| DE (1) | DE69921804T2 (de) |
| ES (1) | ES2230853T3 (de) |
| HU (1) | HUP0102367A3 (de) |
| ID (1) | ID27285A (de) |
| IL (1) | IL139710A (de) |
| NO (1) | NO20005766L (de) |
| NZ (1) | NZ507143A (de) |
| PL (1) | PL197181B1 (de) |
| PT (1) | PT1077930E (de) |
| RU (1) | RU2205823C2 (de) |
| SK (1) | SK286247B6 (de) |
| TR (1) | TR200003355T2 (de) |
| WO (1) | WO1999059960A1 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
| GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
| DK1017378T3 (da) | 1997-09-23 | 2003-03-17 | Astrazeneca Ab | Amidderivater til behandling af sygdomme medieret af cytokiner |
| IL139710A (en) | 1998-05-15 | 2005-07-25 | Astazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
| US6579872B1 (en) | 1998-05-15 | 2003-06-17 | Astrazeneca Ab | Bezamide derivatives for the treatment of diseases mediated by cytokines |
| US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| BR9912729A (pt) | 1998-08-04 | 2001-05-02 | Astrazeneca Ab | Derivado de amida, processo para prepará-lo, e, uso do mesmo |
| ES2221426T3 (es) | 1998-08-20 | 2004-12-16 | Smithkline Beecham Corporation | Nuevos compuestos de triazol sustituidos. |
| ATE254105T1 (de) | 1998-09-25 | 2003-11-15 | Astrazeneca Ab | Benzamid-derivate und ihre verwendung als cytokine inhibitoren |
| US6548503B1 (en) | 1998-11-04 | 2003-04-15 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| EP1163212B1 (de) * | 1999-03-17 | 2005-08-31 | AstraZeneca AB | Amid-derivate |
| DE60010448T2 (de) | 1999-03-17 | 2005-04-07 | Astrazeneca Ab | Amid-derivate |
| GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
| GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
| ES2230171T3 (es) | 1999-11-23 | 2005-05-01 | Smithkline Beecham Corporation | Compuestos 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p38 quinasa. |
| JP2003514900A (ja) | 1999-11-23 | 2003-04-22 | スミスクライン・ビーチャム・コーポレイション | CSBP/p38キナーゼ阻害剤としての3,4−ジヒドロ−(1H)−キナゾリン−2−オン化合物 |
| DE60023025T2 (de) | 1999-11-23 | 2006-07-13 | Smithkline Beecham Corp. | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren |
| US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
| US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| WO2002049632A1 (en) * | 2000-12-18 | 2002-06-27 | Institute Of Medicinal Molecular Design. Inc. | Inhibitors against the production and release of inflammatory cytokines |
| JP4361273B2 (ja) | 2001-02-27 | 2009-11-11 | アメリカ合衆国 | 潜在的な血管形成阻害剤としてのサリドマイド類似体 |
| EP1535609A4 (de) * | 2002-06-10 | 2009-01-07 | Inst Med Molecular Design Inc | Nf-kb-aktivierungshemmer |
| WO2004004703A1 (ja) * | 2002-07-04 | 2004-01-15 | Mitsui Chemicals, Inc. | メタフェニレンジアミン誘導体 |
| AU2003245989A1 (en) | 2002-07-09 | 2004-01-23 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
| CA2808646C (en) | 2003-09-17 | 2016-08-23 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Thalidomide analogs as tnf-alpha modulators |
| GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
| US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| JP5324785B2 (ja) | 2005-10-28 | 2013-10-23 | 武田薬品工業株式会社 | 複素環アミド化合物及びその用途 |
| EP1957461B1 (de) * | 2005-11-14 | 2016-11-02 | Genentech, Inc. | Bisamid-hemmer der hedgehog-signalisierung |
| EP2004614B1 (de) | 2006-04-13 | 2016-10-19 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Tetrahalogenierte verbindungen als angiogenesehemmer |
| US7671058B2 (en) * | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
| WO2008089034A2 (en) * | 2007-01-11 | 2008-07-24 | Kemia, Inc. | Cytokine inhibitors |
| EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
| US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
| CN104326937B (zh) * | 2014-09-03 | 2016-08-24 | 天津市肿瘤研究所 | 抗肿瘤化合物及其医药用途 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1903899A (en) | 1933-04-18 | Cabboxylic acid abylides oe the benzene sebies and process oe making | ||
| US1909960A (en) | 1929-08-06 | 1933-05-23 | Du Pont | Intermediate for azo dyes |
| DE2812252A1 (de) | 1978-03-21 | 1979-10-04 | Bayer Ag | 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel |
| US4524168A (en) | 1981-11-18 | 1985-06-18 | Ciba-Geigy Corporation | Process for the mass coloration of polymers |
| US4749729A (en) | 1984-06-21 | 1988-06-07 | American Cyanamid Company | Epoxy resin compositions curable above 160 F. and below 250 F. |
| WO1993004170A1 (en) | 1991-08-23 | 1993-03-04 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Raf protein kinase therapeutics |
| GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
| CA2228050A1 (en) | 1995-08-10 | 1997-02-20 | Harold G. Selnick | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| CA2502764A1 (en) | 1995-08-22 | 1997-03-06 | Japan Tobacco Inc. | Amide compounds |
| GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
| WO1998006715A1 (en) * | 1996-08-09 | 1998-02-19 | Smithkline Beecham Corporation | Novel piperazine containing compounds |
| GB9623833D0 (en) * | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
| DK1017378T3 (da) | 1997-09-23 | 2003-03-17 | Astrazeneca Ab | Amidderivater til behandling af sygdomme medieret af cytokiner |
| GB9809347D0 (en) | 1998-05-05 | 1998-07-01 | Reckitt & Colmann Prod Ltd | Compositions |
| IL139710A (en) | 1998-05-15 | 2005-07-25 | Astazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
| US6579872B1 (en) | 1998-05-15 | 2003-06-17 | Astrazeneca Ab | Bezamide derivatives for the treatment of diseases mediated by cytokines |
| BR9912729A (pt) | 1998-08-04 | 2001-05-02 | Astrazeneca Ab | Derivado de amida, processo para prepará-lo, e, uso do mesmo |
| ATE254105T1 (de) | 1998-09-25 | 2003-11-15 | Astrazeneca Ab | Benzamid-derivate und ihre verwendung als cytokine inhibitoren |
| CN1158266C (zh) | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
| EP1163212B1 (de) | 1999-03-17 | 2005-08-31 | AstraZeneca AB | Amid-derivate |
| DE60010448T2 (de) | 1999-03-17 | 2005-04-07 | Astrazeneca Ab | Amid-derivate |
| GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
-
1999
- 1999-05-11 IL IL13971099A patent/IL139710A/xx not_active IP Right Cessation
- 1999-05-11 DE DE69921804T patent/DE69921804T2/de not_active Expired - Fee Related
- 1999-05-11 CA CA002328699A patent/CA2328699A1/en not_active Abandoned
- 1999-05-11 US US09/674,428 patent/US6465455B1/en not_active Expired - Fee Related
- 1999-05-11 ES ES99921018T patent/ES2230853T3/es not_active Expired - Lifetime
- 1999-05-11 BR BR9910467-9A patent/BR9910467A/pt not_active Application Discontinuation
- 1999-05-11 KR KR1020007012666A patent/KR100628284B1/ko not_active Expired - Fee Related
- 1999-05-11 PT PT99921018T patent/PT1077930E/pt unknown
- 1999-05-11 RU RU2000131610/04A patent/RU2205823C2/ru not_active IP Right Cessation
- 1999-05-11 CN CNB998061441A patent/CN1188389C/zh not_active Expired - Fee Related
- 1999-05-11 PL PL344185A patent/PL197181B1/pl not_active IP Right Cessation
- 1999-05-11 AT AT99921018T patent/ATE282023T1/de not_active IP Right Cessation
- 1999-05-11 ID IDW20002240A patent/ID27285A/id unknown
- 1999-05-11 SK SK1717-2000A patent/SK286247B6/sk unknown
- 1999-05-11 TR TR2000/03355T patent/TR200003355T2/xx unknown
- 1999-05-11 NZ NZ507143A patent/NZ507143A/en unknown
- 1999-05-11 JP JP2000549579A patent/JP2003505337A/ja not_active Withdrawn
- 1999-05-11 WO PCT/GB1999/001491 patent/WO1999059960A1/en not_active Ceased
- 1999-05-11 HU HU0102367A patent/HUP0102367A3/hu unknown
- 1999-05-11 AU AU38392/99A patent/AU748397B2/en not_active Ceased
- 1999-05-11 EP EP99921018A patent/EP1077930B1/de not_active Expired - Lifetime
-
2000
- 2000-11-14 NO NO20005766A patent/NO20005766L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69921804D1 (de) | 2004-12-16 |
| AU748397B2 (en) | 2002-06-06 |
| NO20005766L (no) | 2001-01-12 |
| BR9910467A (pt) | 2001-01-09 |
| NO20005766D0 (no) | 2000-11-14 |
| TR200003355T2 (tr) | 2001-03-21 |
| KR100628284B1 (ko) | 2006-09-27 |
| CN1359371A (zh) | 2002-07-17 |
| CA2328699A1 (en) | 1999-11-25 |
| HK1033753A1 (en) | 2001-09-21 |
| PL197181B1 (pl) | 2008-03-31 |
| NZ507143A (en) | 2003-08-29 |
| HUP0102367A3 (en) | 2002-11-28 |
| CN1188389C (zh) | 2005-02-09 |
| SK286247B6 (sk) | 2008-06-06 |
| IL139710A0 (en) | 2002-02-10 |
| DE69921804T2 (de) | 2005-10-27 |
| AU3839299A (en) | 1999-12-06 |
| IL139710A (en) | 2005-07-25 |
| US6465455B1 (en) | 2002-10-15 |
| JP2003505337A (ja) | 2003-02-12 |
| HUP0102367A2 (hu) | 2001-10-28 |
| SK17172000A3 (sk) | 2001-04-09 |
| WO1999059960A1 (en) | 1999-11-25 |
| EP1077930A1 (de) | 2001-02-28 |
| PL344185A1 (en) | 2001-10-08 |
| PT1077930E (pt) | 2005-03-31 |
| EP1077930B1 (de) | 2004-11-10 |
| ID27285A (id) | 2001-03-22 |
| KR20010043547A (ko) | 2001-05-25 |
| ES2230853T3 (es) | 2005-05-01 |
| RU2205823C2 (ru) | 2003-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921804D1 (de) | Benzamid-derivate zur behandlung cytokin-vermittelter krankheiten | |
| ATE229329T1 (de) | Amide derivativen zur behandlung von durch cytokinen vermittelten krankheiten | |
| DK496089A (da) | Biologisk aktive phenylalkansyreforbindelser og fremgangsmaade til fremstilling deraf | |
| DE3888568D1 (de) | Menschliche peptidische Hemmungsstoffe von Leukozyten-Elastase (HLE). | |
| MY142177A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
| HUP0102295A2 (hu) | Citokinek által közvetített betegségek kezelésére alkalmas benzamid-származékok | |
| NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
| DE60022328D1 (de) | Amid-derivate | |
| NO992336L (no) | Raf-kinase-inhibitorer | |
| ATE103812T1 (de) | Zusammensetzung zur behandlung von ischaemischen stoerungen in organen. | |
| IL111036A0 (en) | Beta_alanine derivatives, processes for the preparon thereof and pharmaceutical compositions containing the same | |
| NZ308398A (en) | 2-amino benzoxazin-4-one derivatives and medicaments | |
| ATE148109T1 (de) | Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids | |
| ATE88176T1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
| ATE191643T1 (de) | Substituierte beta-diketone und deren verwendung zur behandlung von entzündlichen eingeweidenerkrankungen | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| RU95117692A (ru) | Щелочные соли амидов оротовой кислоты и аминокислот, обладающие гипертензивной активностью | |
| RU94033470A (ru) | Циклогексановые производные, фармкомпозиция на их основе и способ лечения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1077930 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |